Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
1.060
+0.005 (0.47%)
At close: Nov 4, 2024, 4:00 PM
1.000
-0.060 (-5.66%)
After-hours: Nov 4, 2024, 7:54 PM EST
Silo Pharma Employees
Silo Pharma had 3 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$24,034
Profits / Employee
-$1,171,594
Market Cap
4.75M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3 | 0 | - |
| Dec 31, 2022 | 3 | 1 | 50.00% |
| Dec 31, 2021 | 2 | 1 | 100.00% |
| Dec 31, 2020 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| IM Cannabis | 95 |
| Fresh2 Group | 75 |
| Predictive Oncology | 35 |
| ENDRA Life Sciences | 21 |
| Aethlon Medical | 14 |
| Galmed Pharmaceuticals | 8 |
| Evoke Pharma | 4 |
| Lixte Biotechnology Holdings | 4 |
SILO News
- 4 days ago - Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant - GlobeNewsWire
- 7 weeks ago - Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSD - GlobeNewsWire
- 2 months ago - Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic - GlobeNewsWire
- 3 months ago - Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide - GlobeNewsWire
- 3 months ago - Silo Pharma to Present at H.C. Wainwright Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 3 months ago - Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 3 months ago - Silo Pharma Finds Partner For Device Development for Intranasal PTSD Drug - Benzinga